AU7960094A - Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals - Google Patents

Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals

Info

Publication number
AU7960094A
AU7960094A AU79600/94A AU7960094A AU7960094A AU 7960094 A AU7960094 A AU 7960094A AU 79600/94 A AU79600/94 A AU 79600/94A AU 7960094 A AU7960094 A AU 7960094A AU 7960094 A AU7960094 A AU 7960094A
Authority
AU
Australia
Prior art keywords
radiopharmaceuticals
compositions
methods
magnetic resonance
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79600/94A
Inventor
Julie A Beaty
Stephen Cooper
T. Jeffrey Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Publication of AU7960094A publication Critical patent/AU7960094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/189—Host-guest complexes, e.g. cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1268—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2604/00—Fullerenes, e.g. C60 buckminsterfullerene or C70

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Signal Processing (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU79600/94A 1993-10-04 1994-09-30 Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals Abandoned AU7960094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13034293A 1993-10-04 1993-10-04
US130342 1993-10-04
PCT/US1994/010999 WO1995009564A1 (en) 1993-10-04 1994-09-30 Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals

Publications (1)

Publication Number Publication Date
AU7960094A true AU7960094A (en) 1995-05-01

Family

ID=22444238

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79600/94A Abandoned AU7960094A (en) 1993-10-04 1994-09-30 Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals

Country Status (4)

Country Link
EP (1) EP0722291A1 (en)
JP (1) JPH09503765A (en)
AU (1) AU7960094A (en)
WO (1) WO1995009564A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420066A3 (en) * 1998-03-10 2005-01-05 Fujisawa Pharmaceutical Co., Ltd. Use of fullerene derivatives as DNA compaction agent
WO2015200187A1 (en) 2014-06-27 2015-12-30 Reiley Pharmaceuticals, Inc. Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging
WO2016111834A1 (en) 2015-01-09 2016-07-14 Reiley Pharmaceuticals, Inc. Cox-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223479A (en) * 1991-08-01 1993-06-29 The Trustees Of The University Of Pennsylvania Process for preparing alkali metal-doped fullerenes
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
US5177248A (en) * 1991-10-28 1993-01-05 Exxon Research And Engineering Company Process of forming polysubstituted fullerenes
GB9203037D0 (en) * 1992-02-11 1992-03-25 Salutar Inc Contrast agents

Also Published As

Publication number Publication date
JPH09503765A (en) 1997-04-15
WO1995009564A1 (en) 1995-04-13
EP0722291A1 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
AU2157395A (en) Gas filled microspheres as magnetic resonance imaging contrast agents
GB2282227B (en) Nuclear magnetic resonance tomography apparatus
AU6517794A (en) Magnetic resonance imaging assisted cryosurgery
AU2187995A (en) X-ray imaging system
EP0746949A4 (en) Synthesized stereoscopic imaging system and method
AU3359889A (en) Contrast agents for magnetic resonance imaging
EP0620447A3 (en) Altered dipole moment magnetic resonance imaging method.
AU3390697A (en) Force-detected nuclear magnetic resonance
AU8632591A (en) Novel compositions for magnetic resonance imaging
AU4341289A (en) Methods and compositions for magnetic resonance imaging
GB9626070D0 (en) Nuclear magnetic resonance imaging apparatus
AU3973193A (en) Radiopharmaceuticals for imaging the heart
GB2276942B (en) NMR Imaging techniques
AU6408594A (en) X-ray imaging system and solid state detector therefor
AU1256595A (en) Gamma ray imaging system
AU2419695A (en) Contrast medium for magnetic resonance imaging
AU2908092A (en) Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same
EP0638815A3 (en) Method of nuclear spin tomography imaging for creating RARE-images with additional preparation of the magnetization for contrast variation.
AU7960094A (en) Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals
GB9624722D0 (en) Nuclear magnetic resonance imaging apparatus
GB9419040D0 (en) Gamma ray imaging
GB9704854D0 (en) Nuclear magnetic resonance imaging apparatus
GB9306776D0 (en) Fingerpring imaging
AU4287996A (en) X-ray imaging device
AU1154292A (en) Contrast agents for magnetic-resonance imaging